Infect Immun, May 1998, p. 2352-2355, Vol. 66, No. 5
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Chlamydia trachomatis Infection of Human
Mesothelial Cells Alters Proinflammatory, Procoagulant, and
Fibrinolytic Responses
Mireille
van
Westreenen,1,*
Apollo
Pronk,1
Rob J. A.
Diepersloot,2
Philip G.
de Groot,3 and
Piet
Leguit1
Departments of
Surgery1 and
Microbiology,2 Diakonessen Hospital, and
Department of Hematology, The University Hospital
Utrecht,3 Utrecht, The Netherlands
Received 25 August 1997/Returned for modification 9 October
1997/Accepted 2 February 1998
 |
ABSTRACT |
In this study we demonstrate the capability of Chlamydia
trachomatis to infect cultured human mesothelial cell (MC)
monolayers and to induce the production of the proinflammatory
cytokines interleukin 1
(IL-1
) and IL-8. Seventy-two hours after
initial infection, both the procoagulant activity of MC and the
activity of the fibrinolytic inhibitor (plasminogen activator inhibitor 1) in the supernatants were enhanced. These findings support the hypothesis that provoked proinflammatory responses contribute to the
development of complications after chlamydial infection.
 |
TEXT |
Chlamydial infections of the
urogenital tract are frequently asymptomatic but can result in
severe complications, particularly in women. Although Chlamydia
trachomatis preferentially infects the columnar or transitional
epithelium, this microorganism can also induce more invasive infections
causing Fitz-Hugh-Curtis syndrome (8). Progression and
complications induced by ascending C. trachomatis infections
may depend on local immunologically mediated inflammation and fibrosis
(6, 9, 11, 18). However, little is known about the
pathogenesis of this infection. We initiated infection of human
mesothelial cells (MC) with C. trachomatis and studied
proinflammatory, fibrinolytic, and procoagulant responses during one
life cycle (24- to 72-h period).
MC were obtained from the omental tissue during a patient's elective
abdominal surgery. The MC were isolated according to techniques
modified from the work of Nicholson et al. (10) and Wu et
al. (22) and cultured as described previously
(23). The identity of MC was demonstrated by the absence of
von Willebrand factor staining (13) and the presence of
intracellular cytokeratins by immunofluorescence with monoclonal
antibodies (Dakopatts, Glostrup, Denmark) (5).
A C. trachomatis clinical urogenital isolate was used
for all experiments. Strains were propagated on a buffalo
green monkey (BGM) cell line with minimal essential medium with
Earle's salts (Life Technologies Ltd., Paisley, Scotland) supplemented
with 10% fetal calf serum. Confirmation of strain identity was
performed with a monoclonal antibody (De Beer Medicals, Diessen, The
Netherlands).
MC monolayers (second passage) grown to confluence in 48-well tissue
culture plates were used for infection experiments. Heat-inactivated (30 min at 56°C) and ultracentrifuged (2 h at 100,000 × g) C. trachomatis suspensions were also
investigated. MC monolayers incubated with 500 and 100 µl of
sucrose-phosphate-glutamic acid (SPG) served in all experiments as the
control medium. After 24 h the conditioned
medium was collected and centrifuged (800 × g). The supernatants were stored at
70°C for
immunoassessment. Fresh supplemented M-199 was added to the MC
monolayers at 24 and 48 h after initial infection. For
quantification of infection, cells were fixed for 30 min in absolute
methanol-acetone, air dried, and stained by fluorescein-conjugated
murine monoclonal antibodies and examined microscopically for
inclusions. The number of inclusion-forming units was counted in 10 random fields at a ×200 magnification. MC toxicity was assessed by
examining the monolayers under phase-contrast microscopy and by
measurement of lactate dehydrogenase activity (2, 4).
Interleukin 1
(IL-1
) and IL-8 were detected by an enzyme-linked
immunosorbent assay (Pelikine-compact; Central Laboratory of The
Netherlands Red Cross Blood Transfusion Service, Amsterdam, The
Netherlands). Quantification of PAI-1 activity was also
determined in the same supernatants by means of an
enzyme-linked immunosorbent assay (Spectrolyse; Biopool, Umea,
Sweden). Determinations were done in duplicate, while
all experiments were performed in triplicate. Procoagulant
studies were performed in 48-well tissue culture plates at 37°C and
assayed as described previously (21). Tissue factor (TF) expression was
quantified as the amount of pM factor Xa formed per minute by
105 MC compared with the amount formed in the control
medium (100%).
Results are expressed as means and standard deviations (SD). The
data were subjected to statistical analysis by the paired two-tailed Student t test, where groups were compared with
the control.
Susceptibility and cell damage of MC monolayers.
MC were
highly susceptible to infection with C. trachomatis.
Significant cell injury occurred 72 h after initial infection for
nondiluted (1:1) and diluted (1:5) chlamydia suspensions (data not shown). Therefore, a 1:10 dilution of the chlamydia stock solution was used in all subsequent experiments. The actual infection percentage of MC monolayers after 48 h of incubation with a
1:10-diluted stock solution of C. trachomatis was
comparable to that of the standard BGM cell line, i.e.,
approximately 17% (30 inclusion bodies per 500 MC at a ×200
magnification).
IL-1
and -8 production by human MC.
Unstimulated cultured
MC monolayers released small amounts of IL-1
(28.2 ± 7.4 pg)
and IL-8 (1.38 ± 0.2 ng) during incubation with control medium
(M-199 with 0.2% SPG). When MC were cultured with viable chlamydiae,
IL-1
concentrations in the supernatants reached maximal levels
72 h after initiation of cultures (78.9 ± 13.5 pg) (Fig.
1). The release of IL-8 in response to
infection with a 1:10-diluted stock of C. trachomatis rose
significantly above background levels after 24 to 48 h (2.0 ± 0.4 ng) and rapidly increased after 48 to 72 h (11.9 ± 3.9 ng) of incubation. Heat-killed chlamydiae were ingested by MC,
and no intracellular growth was observed (Fig.
2). Figure 1 also indicates that
heat-killed C. trachomatis significantly enhanced the amount
of IL-1
0 to 24 h after initial infection and failed to induce
the amount of IL-8 during the 72-h period.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 1.
IL-1 and -8 concentrations in the supernatants of MC
monolayers infected with C. trachomatis. Levels are
expressed as mean IL-1 concentrations (±SD) and IL-8 concentrations
(±SD) per 105 MC based on results from four separate
experiments performed in duplicate. Patterns in bars reflect lengths of
incubation, as follows: , 0 to 24 h; , 24 to 48 h; and
, 48 to 72 h. *, P < 0.05; ,
P < 0.01. Statistically significant differences
reflect comparisons with MC monolayers exposed to control medium
(supplemented M-199 containing 0.2% [vol/vol] SPG medium). inact.,
inactivated; ultracentr., ultracentrifuged.
|
|

View larger version (137K):
[in this window]
[in a new window]
|
FIG. 2.
Phase-contrast microscopy of chlamydia incorporation
during 48 h of incubation with a 1:10-diluted stock
suspension of viable C. trachomatis (A) and a suspension of
heat-killed chlamydiae (B). Magnification, ×188. Arrows indicate
intracellular fluorescent chamydiae.
|
|
Procoagulant and antifibrinolytic activities of human MC.
Without cells or without one of the clotting factors (VII or X),
no Xa was formed. As a positive control we used phorbol myristate acetate (10 ng/ml). Forty-eight hours after initial chlamydial infection, TF expression was significantly induced. Compared to the
level of TF expression in the negative control, a 1.5-fold increase was
observed (Fig. 3).

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 3.
TF activity of MC monolayers 72 h after initial
infection with C. trachomatis. Results are depicted as mean
amounts of factor Xa generated (± standard errors) and are based on
values from four separate experiments performed in triplicate. *,
P < 0.05. Statistically significant differences
reflect comparisons with MC monolayers exposed to control medium
(supplemented M-199 containing 0.2% [vol/vol] SPG medium). inact.,
inactivated; ultracentr., ultracentrifuged.
|
|
The supernatants from unstimulated, noninfected, and infected MC
monolayers were assessed for fibrinolytic activity by enzyme-linked
| 1.
|
Agace, W. W.,
S. R. Hedges,
M. Ceska, and C. Svanborg.
1993.
Interleukin-8 and the neutrophil response to mucosal gram-negative infection.
J. Clin. Invest.
92:780-785.
|
| 2.
|
Bergmeyer, H. U.,
E. Bernt, and B. Hess.
1965.
Lactate dehydrogenase (II 2a), p. 736-743.
In
H. U. Bergmeyer (ed.), Methods of enzymatic analysis 1965. Academic Press, New York, N.Y.
|
| 3.
|
Bobo, L.,
N. Novak,
H. Mkocha,
S. Vitale,
S. West, and T. C. Quinn.
1996.
Evidence for a predominant proinflammatory conjuctival cytokine response in individuals with trachoma.
Infect. Immun.
64:3273-3279[Abstract].
|
| 4.
|
Breborowiczs, A.,
H. Rodela, and D. G. Oreopouos.
1992.
Toxicity of osmotic solutions on human mesothelial cells in vitro.
Kidney Int.
41:1280-1285[Medline].
|
| 5.
|
Connell, N. D., and J. G. Rheinwald.
1983.
Regulation of the cytoskeleton in mesothelial cells: reversible loss of keratin and increase in vimentin during rapid growth in culture.
Cell
34:245[Medline].
|
| 6.
|
Dörr, P. J.,
E. J. P. Brommer,
G. Dooijewaard, and H. M. Vemer.
1992.
Peritoneal fluid and plasma fibrinolytic activity in women with pelvic inflammatory disease.
Thromb. Haemostasis
68:102-105[Medline].
|
| 7.
|
Douvdevani, A.,
J. Rapoport,
A. Konforty,
S. Argov,
A. Ovnat, and C. Chaimovitz.
1994.
Human peritoneal mesothelial cells synthesize IL-1 and .
Kidney Int.
46:993-1001[Medline].
|
| 8.
|
Heinonen, P. K.,
K. Teisela,
R. Punnonen,
A. Miettenen,
M. Lehtinen, and J. Pavoonen.
1985.
Anatomic sites of upper genital tract infection.
Obstet. Gynecol.
66:348-390.
|
| 9.
|
Malinverni, R.
1996.
The role of cytokines in chlamydial infections.
Curr. Opin. Infect. Dis.
9:150-155.
|
| 10.
|
Nicholson, L. J.,
J. M. F. Clarke,
R. M. Pittilo,
S. J. Machin, and N. Woolf.
1984.
The mesothelial cell as a non-thrombogenic surface.
Thromb. Haemostasis
52:102-104[Medline].
|
| 11.
|
Patton, D. L.
1985.
Immunopathology and histopathology of experimental salpingitis.
Rev. Infect. Dis.
7:746-753[Medline].
|
| 12.
|
Patton, D. L., and C. C. Kuo.
1989.
Histopathology of Chlamydial trachomatis salpingitis after primary and repeated reinfections in the monkey subcutaneous pocket model.
J. Reprod. Fertil.
85:647-656[Abstract].
|
| 13.
|
Pronk, A.,
P. G. de Groot,
A. A. G. M. Hoynck van Papendrecht,
H. A. Verbrugh,
P. Leguit,
T. J. M. V. van Vroonhoven, and J. J. Sixma.
1992.
Thrombogenicity and procoagulant activity of human mesothelial cells.
Arterioscler. Thromb.
12:1428-1436[Abstract/Free Full Text].
|
| 14.
|
Rank, R. G.,
M. M. Sanders, and A. T. Kidd.
1993.
Influence of the estrous cycle on the development of upper genital tract pathology as a result of chlamydial infection in the guinea pig model of pelvic inflammatory disease.
Am. J. Pathol.
142:1291-1296[Abstract].
|
| 15.
|
Rapaport, S. I.
1991.
Regulation of the tissue factor pathway.
Ann. N. Y. Acad. Sci.
614:51-62[Medline].
|
| 16.
|
Rasmussen, S. J.,
L. Eckmann,
A. J. Quayle,
L. Shen,
Y.-X. Zhang,
D. J. Anderson,
J. Fierer,
R. S. Stephens, and M. F. Kagnoff.
1997.
Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis.
J. Clin. Invest.
99:77-87[Medline].
|
| 17.
|
Rothermel, C. D.,
J. Schachter,
P. Lavrich,
E. C. Lipsitz, and T. Francus.
1989.
Chlamydia trachomatis-induced production of interleukin-1 by human monocytes.
Infect. Immun.
57:2705-2711[Abstract/Free Full Text].
|
| 18.
|
Taylor, H. R.,
S. L. Johnson,
J. Schachter,
H. D. Caldwell, and R. A. Prendergast.
1987.
Pathogenesis of trachoma: the stimulus for inflammation.
J. Immunol.
138:3023-3027[Abstract].
|
| 19.
|
Thompson, J. N.,
S. Paterson-Brown,
T. Harbourne,
S. A. Whawell,
E. Kalodiki, and H. A. F. Dudley.
1989.
Reduced human peritoneal plasminogen activity: possible mechanism of adhesion formation.
Br. J. Surg.
76:382-384[Medline].
|
| 20.
|
Topley, N.,
Z. Brown,
A. Jörres,
J. Westwick,
M. Davies,
G. A. Coles, and J. D. Williams.
1993.
Human peritoneal mesothelial cells synthesize interleukin-8. Synergistic induction by IL-1 and TNF- .
Am. J. Pathol.
142:1876-1886[Abstract].
|
| 21.
|
Verhagen, H. J. M.,
G. J. Heijnen-Snyder,
T. Vink,
A. Pronk,
T. J. M. V. van Vroonhoven,
B. C. Eikelboom,
J. J. Sixma, and P. G. de Groot.
1995.
Tissue factor expression on mesothelial cells is induced during in vitro culture manipulation of culture conditions creates perspectives for mesothelial cells as a source for cell seeding procedures on vascular grafts.
Thromb. Haemostasis
74:1096-1102[Medline].
|
| 22.
|
Wu, Y.-J.,
T. M. O'Connel, and J. G. Rheinwald.
1983.
Human mesothelial cell culture.
Cell
31:693-703.
|
| 23.
|
Zeillemaker, A. M.,
F. J. P. Mul,
A. A. G. M. Hoynck van Papendrecht,
T. W. Kuijpers,
D. Roos,
P. Leguit, and H. A. Verbrugh.
1996.
Neutrophil adherence to and migration across monolayers of human peritoneal cells.
J. Lab. Clin. Med.
127:279-286[Medline].
|